Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12.7M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
1.71M
-
Shares change
-
+185K
-
Total reported value, excl. options
-
$24.3M
-
Value change
-
+$2.58M
-
Number of buys
-
14
-
Number of sells
-
-13
-
Price
-
$14.13
Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q1 2018
38 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q1 2018.
IRADIMED CORP - Common Stock (IRMD) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.71M shares
of 12.7M outstanding shares and own 13.43% of the company stock.
Largest 10 shareholders include AMERIPRISE FINANCIAL INC (470K shares), VANGUARD GROUP INC (194K shares), Ranger Investment Management, L.P. (128K shares), CADENCE CAPITAL MANAGEMENT LLC (113K shares), Boston Partners (74.5K shares), Menta Capital LLC (66.5K shares), Russell Investments Group, Ltd. (59.1K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (55.9K shares), RENAISSANCE TECHNOLOGIES LLC (53.5K shares), and Eversept Partners, LP (51.1K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.